Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

78.34 +0.55 (+0.71%)
Streaming Delayed Price Updated: 10:38 AM EST, Dec 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9
...
58 59 Next >
News headline image
3 Absurdly Cheap Stocks You Can Buy For Less than $100 Right Now ↗
The stocks listed here trade at forward earnings multiples of less than 18. 
Via The Motley Fool
News headline image
2 Dividend Stocks to Buy for 2026 and Beyond ↗
The healthcare sector is a great place to find quality income stocks, and these two appear to be strong picks. 
Via The Motley Fool
News headline image
Humana, Molina Jump As House GOP Revolt Reignites Fight To Extend Obamacare Subsidies — Retail Warns ‘Healthcare Wreck’ ↗
Health insurance stocks split after a House GOP revolt revived debate over ACA subsidies, while a year-end extension was ruled out. 
Via Stocktwits
News headline image
CVS Health Corp (NYSE:CVS) Shows High Technical and Setup Ratings for Potential Breakout ↗
CVS Health Corp shows strong technical momentum and a perfect basing setup, signaling a potential breakout opportunity for chart-focused traders. 
Via Chartmill
News headline image
1 Healthcare Stock to Research Further and 2 That Underwhelm
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have... 
Via StockStory
Topics Stocks
News headline image
Small-Cap Surge Signals Major Market Rebalancing: Investors Pivot from Tech to Broader Economy
Small-capitalization stocks are currently experiencing an unprecedented surge, with the benchmark Russell 2000 index shattering all-time records in early December 2025. This remarkable rally, which saw... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
3 Reasons CVS is Risky and 1 Stock to Buy Instead
CVS Health’s 22.1% return over the past six months has outpaced the S&P 500 by 8.7%, and its stock price has climbed to $78.44 per share. This was partly thanks to its solid quarterly results, and the... 
Via StockStory
Topics Stocks
News headline image
Meet the 2.5% Yield Dividend Stock That Could Soar in 2026 ↗
UnitedHealth Group raised its dividend in each of the last 16 years. 
Via The Motley Fool
News headline image
Glenview Capital Management Sells $71 Million of Alight Stake After Stock's 71% Drop ↗
Glenview Capital Management reduced its stake in Alight by roughly 16% during the third quarter. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why CVS Health (CVS) Stock Is Up Today
Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 3.2% in the morning session after the company raised its financial guidance for 2025 and provided a strong forecast for 2026 at its... 
Via StockStory
Topics Artificial Intelligence
News headline image
Glenview Doubles Down on Teva Stock With $72 Million Buy, According to Recent SEC Filing ↗
Glenview Capital Management added to its massive position in Teva Pharmaceuticals stock. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 S&P 500 Stock Worth Your Attention and 2 We Turn Down
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Stocks
News headline image
2 Soaring Healthcare Stocks to Buy and Hold for a Decade ↗
HCA Healthcare and CVS Health are firing on all cylinders. 
Via The Motley Fool
News headline image
Q3 Earnings Review: Health Insurance Providers Stocks Led by CVS Health (NYSE:CVS)
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including CVS Health (NYSE:CVS) and its... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
The State Street Consumer Staples ETF Offers Sharper Focus and Lower Costs Than The iShares US Consumer Staples ETF ↗
Expense ratios, sector focus, and portfolio makeup set these two consumer staples ETFs apart for investors seeking the right fit. 
Via The Motley Fool
Topics ETFs
News headline image
2 Large-Cap Stocks with Exciting Potential and 1 Facing Challenges
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Forget CVS, Buy This Healthcare Stock Instead ↗
This healthcare stock has struggled this year, but things are suddenly looking up. 
Via The Motley Fool
Topics Government
News headline image
3 Value Stocks We Keep Off Our Radar
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
Via StockStory
News headline image
CVS Pays $18.3 Million To Resolve Alleged Medi-Cal Billing Failures ↗
CVS agrees to an $18.3 million settlement resolving allegations it sought Medi-Cal reimbursement for prescriptions. 
Via Benzinga
News headline image
Health Insurance Providers Stocks Q3 Highlights: Cigna (NYSE:CI)
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including Cigna (NYSE:CI) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
Trump's Bond Buying Spree Surges Past $82 Million Since August ↗
Trump bought over $82 million in bonds, intersecting with sectors boosted by his policies. Disclosures show 175+ transactions. 
Via Benzinga
Topics Bonds Government
News headline image
Hedge Fund Sells $25.6 Million in Paramount Group Stock as Rithm's $1.6 Billion Deal Looms ↗
A surprising office-sector exit by a steady fund may reveal more about opportunity cost than pessimism. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
What One Hedge Fund's $29.6 Million Bet on First American Signals About the U.S. Housing Market ↗
One quiet hedge fund is making a contrarian move on a real-estate-linked stock just as the housing market starts to turn. 
Via The Motley Fool
News headline image
Why One Fund Just Invested $21 Million in This Once High-Flying Software Stock ↗
This hedge fund just made a bold move into a once-hyped software name that’s now trading at a steep discount. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
David Tepper's Contrarian Bet on UnitedHealth Group (UNH) Pays Off Amidst Market Volatility
In a move that has captured the attention of the financial world, legendary investor David Tepper, through his firm Appaloosa Management, made a significant contrarian bet on healthcare giant... 
Via MarketMinute
Topics Economy
News headline image
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever. ↗
These companies are demonstrating their ability to deal with significant business risks. 
Via The Motley Fool
News headline image
3 Stocks That Have Made Epic Comebacks in 2025 ↗
Last year was a bad one for these stocks, but buying them on weakness would have proven to be a great move for investors. 
Via The Motley Fool
Topics Government
News headline image
A Look Into CVS Health Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
Eli Lilly Drops CVS Health's Drug Benefit Plan For Employees Ahead Of 2026 Switch ↗
Eli Lilly to drop CVS Health's drug benefit plan and move to Rightway in 2026 as Novo Nordisk cuts Wegovy prices in India to defend market share. 
Via Benzinga
News headline image
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' ↗
Eli Lilly CEO Dave Ricks slams PBM "rent taking" for driving $275 insulin price bubble and explains why he's ready to "disintermediate them." 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
58 59 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.